This update corrects the spelling of the new company. It is Pronota, not Pronata.
NEW YORK (GenomeWeb News) — Belgian company Peakadilly has changed its name to Pronota to reflect its emphasis on protein biomarker discovery, the firm said today.
The company also said that a recent €8.5 million ($10.97 million) financing round has enabled it to expand its staff, equipment, and facilities, which it will use to position itself more squarely in the protein biomarker market.
Pronota said its signature biomarker technology, the MASStermind, is used to analyze proteomes from samples such as blood. It also plans to use the technology to develop new diagnostic disease screens and therapeutics.